Lidocaine injection before throat cancer surgery
Treatments studied
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This early-phase trial tests whether injecting lidocaine (a numbing medicine) into the tumor before surgery can help with pain or other outcomes in people with oropharyngeal cancer. It's for patients who are already scheduled for a scope procedure and surgery at the University of Pennsylvania.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with squamous cell carcinoma of the oropharynx (back of the throat) or neck.
- Your tumor is at a stage T1, T2, T3, or T4 (any stage of local spread).
- You are planning to have a direct laryngoscopy (scope to look at the throat) with or without biopsy at the University of Pennsylvania.
- You have not had radiation therapy to the head or neck before.
- You are not allergic to lidocaine or similar numbing medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests injecting a chemotherapy drug (cisplatin with epinephrine) directly into throat tumors, given once a week for 3 weeks before planned surgery. It is for people whose throat cancer has come back after radiation and who need surgery to remove it.
This Phase 2 trial tests giving the immunotherapy drug sintilimab before surgery, along with fewer chemotherapy cycles. The goal is to shrink or control oral or throat squamous cell cancers while keeping side effects lower, before the tumor is removed.
This trial is testing a surgical approach for people with HPV-related oropharyngeal cancer that is stage I or II (but not the very smallest). The goal is to see if removing the tumor through the mouth and taking out neck lymph nodes is effective and safe. It may be an option if you are healthy enough for surgery.
This trial tests whether putting lidocaine (a numbing medicine) into the abdomen during surgery can improve comfort or recovery for people having surgery to reduce ovarian cancer. If you are eligible, the research team will compare outcomes with the use of this medicine during your planned operation.
This trial tests if giving lidocaine during lung cancer surgery can reduce the chance of the cancer coming back. It is for people having minimally invasive lung cancer surgery.
This trial tests adding an immunotherapy drug (PD-1 inhibitor) to chemotherapy before surgery for advanced laryngeal or hypopharyngeal cancer. The goal is to see if this combination shrinks tumors more and improves outcomes for patients who need their entire voice box removed.
Hear when a new Oropharyngeal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.